Comment on "Second-Generation Tyrosine Kinase Inhibitors Improve the Survival of Patients With Chronic Myeloid Leukemia in Whom Imatinib Therapy Has Failed" Haematologica 2011;96(12):1779-82

Haematologica - Italy
doi 10.3324/haematol.2011.061630
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)


Related search